INTRODUCTION
Platelet-activating factor [PAF, identified as -O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (AGEPC)] is a biologically active phospholipid which is involved in several physiological and pathophysiological activities, such as allergic reactions [1, 2] , activation of platelets and polymorphonuclear leukocytes [2] [3] [4] , negative inotropic effects in guinea pig heart [5] , hypotension [6] and hepatic glycogenolysis [7, 8] . PAF is produced following appropriate stimuli in several tissues and cells including blood cells [2, 9] , peritoneal and alveolar macrophages [10, 11] , isolated rat kidney cells [12] , human endothelial cells [13, 14] , perfused guinea pig heart [5] , perfused rat liver [15] and rabbit lung [16] .
The metabolism of AGEPC has been studied previously in HL-60 cells [17] , Madin-Darby canine kidney cells [17] , intact rat [18] , transformed and nontransformed mouse embryonic cells [17] , human and rabbit neutrophils [19, 20] , rabbit and human platelets [21] [22] [23] , rat alveolar macrophages [24] , interstitial and epithelial cells from rat lungs [25] , rat capillary endothelial cells [26] , hepatocytes [27] , cultured human endothelial cells [28] and hepatic nonparenchymal cells in the present study. Although most reports have shown that AGEPC is first converted to 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine (lyso-GEPC) which is then reacylated to 1-0-alkyl -2 -acyl -sn -glycero -3 -phosphocholine (alkylacyl -GPC) [17, [19] [20] [21] [22] [23] [24] [25] [26] , it has been suggested that AGEPC is probably transacylated to alkylacyl-GPC directly [21] and that lyso-GEPC is converted to 1-alkyl-2-lysoglycerol via phospholipase C. 1-Alkyl-2-lyso-glycerol then may be converted to fatty aldehyde via alkylmonooxygenase [27] .
There are a limited number of reports on the metabolism of lyso-GEPC. Alam et al. [29] [7, 8] , as this potent autacoid is cleared from the circulation. In fact, previous studies in our laboratory have shown that various particulate sub-
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stances, e.g. heat-aggregated IgG [15] , zymosan, latexcoated beads [37] Rat Kupffer cell suspensions were purified by centrifugal elutriation and cultured as described previously [30] . The viability of Kupffer cells was greater than 95 % as determined by Trypan Blue exclusion.
Incubation conditions and lipid extraction
Before cultured cells were used in an incubation, the maintaining media were carefully removed from the cultured cells and the cells were rinsed twice with 2 ml of 0.1 % bovine serum albumin (BSA) containing serumfree RPMI-1640 media. Kupffer cells (2 x 106) were incubated in 1 ml of the serum-free medium for 10 min at 37°C, and then 0.5 pmol of [3H]AGEPC (0.03 gtCi; 0.5 nm final concentration) was added to each plate. Each incubation was conducted in duplicate or triplicate for the desired time and the metabolic reaction was stopped by quickly removing the media from each plate for subsequent lipid analysis (set A). Then 1 ml of methanol was added to each dish. The cells were scraped with a rubber policeman and each culture dish was rinsed with 1.25 ml of methanol, again for analysis of the component lipids (set B). Lipids in the medium (set A) and the cellular fraction (set B) were extracted separately according to the procedure of Bligh & Dyer [32] . The experiment to characterize the metabolism of [3H]lyso-GEPC in each sample was performed following the same procedure except that 12.5 pmol of lyso-GEPC (1.0 1tCi) was added to each dish instead of [3H]AGEPC.
Thin layer chromatography
The lipid-rich chloroform phase of each sample was collected and evaporated under N2. The residue was immediately dissolved in 100 ,ul of chloroform/methanol (2: 1, v/v) and subjected to t.l.c. on a 250 ,um silica gel H plate (Uniplate, Analtech, Newark, NJ, U.S.A.), with a separate lane containing unlabelled standard polar lipids, i.e. AGEPC, lysophosphatidylcholine (lyso-PC) and phosphatidylcholine (PC). Chromatography was performed using a solvent system of chloroform/ methanol/water (65:35:7, by vol.) as described previously [33, 34] . The standard phospholipids were detected under ultraviolet light after spraying with toluidinyl-2-naphthalenesulphonate (TNS). Each spot of phospholipid was scraped and the amount of radioactivity in each lipid class was determined by lipid scintillation spectrometry.
Data presentation
The quantification of the results of the phospholipid analysis performed in this study is based on the specific radioactivity of the labelled compounds added to the various incubations, except in the recovery study of [3H]AGEPC where the percentage of total radioactivity was used. Unless otherwise stated, all data are presented as the means + S.D. of triplicate determinations and are representative of at least two separate experiments.
RESULTS
Experimental conditions: the effect of BSA on the recovery and the metabolism of 13HIAGEPC by rat
Kupffer cells
The strong adsorption of AGEPC to glassware or plastic cultureware has been observed previously [35] . Therefore, it was important to establish suitable incubation conditions to improve the recovery of AGEPC and its metabolites. We used different concentrations of BSA and observed its effect on lyso-GEPC (Fig. 1) . Also, alkylacyl-GPC, a reacylated metabolite of lyso-GEPC, decreased in the cellular fraction from 21.3 fmol to 8.7 fmol when the concentration of BSA was increased from 0.0025 % to 0.25 %, though this change was not as pronounced as with lyso-GEPC. In contrast, there was an increased retention of [3H]AGEPC in the medium with the increase in the concentration of BSA.
Cellular uptake and metabolism of I3HIAGEPC
Kupffer cells (2 x 106) in 1 ml of medium containing 0.1 0 BSA were incubated with 0.5 pmol of [3H]AGEPC (0.03 #Ci) for the desired time, and the phospholipids were separated and analysed by t.l.c. as described in the Materials and methods section. Three areas of labelled phospholipids were identified and removed by scraping: AGEPC, lyso-GEPC and alkylacyl-GPC. The metabolic products of [3H]AGEPC found in the complete incubation mixture and in the cellular and medium subfractions were analysed and are shown in Figs. 2(a) , 2(b), and 2(c) respectively. Fig. 2(a) Fig. 2(b) . The amount of [3H]AGEPC found intracellularly increased rapidly to 17.9 fmol at 5 min and 21.9 fmol at 10min, then decreased slowly thereafter. At the same time, the amounts of lyso-GEPC and alkylacyl-GPC in the cellular fraction increased at a relatively constant rate ( Fig. 2b) . In the medium fraction (Fig. 2c) , the amount of alkylacyl-GPC showed no significant change, whereas the amount of lyso-GEPC (Fig. 3a ) indicated that the amount of AGEPC rapidly increased from 0.3 pmol at 0 min to 0.4 pmol at 30 min and decreased thereafter. There occurred a 30 min delay in the formation of alkylacyl-GPC compared to AGEPC and the increase in the amount of alkylacyl-GPC was not as much as for AGEPC. When the cellular and the medium fractions were analysed separately, it was found that the cultured Kupffer cells took up [3H]lyso-GEPC in a typical time-dependent manner (Fig. 3b) . Within 10 min of the addition of [3H]lyso-GEPC to the cultured cells, 59.1 fmol of 3H-labelled lipids were found in the cellular fraction, and this increased to 91.5 fmol at 30 min and 110.7 fmol at 60 min. The amount of [3H]lyso-GEPC in the cellular fraction increased rapidly during the first 10 min of incubation (from 1.4 fmol at 0 min to 46.1 fmol at 10 min), reached a maximum level (68.4 fmol) at 30 min, remaining approximately constant for 60 min thereafter. Concomitantly, alkylacyl-GPC associated with the cell fraction increased at a slower but constant rate (Fig. 3b) . Analysis of the medium fraction revealed that during the first 30 min, the amount of [3H]lyso-GEPC decreased rapidly, with a corresponding increase in [3H]AGEPC which then decreased rapidly thereafter; whereas the amount of alkylacyl-GPC in the medium remained almost at the same level (Fig. 3c) .
DISCUSSION
The [17] , rabbit and human platelets [21] [22] [23] , rat lung epithelial cells [25] and rabbit and human neutrophils [19, 20] , where the major metabolite of AGEPC was alkylacyl-GPC, with only a small amount of lyso-GEPC formed. Results similar to the present study have been reported previously in rat capilliary endothelial cells [26] , human endothelial cells [28] and rat alveolar macrophages [24] . The amount of lyso-GEPC and its extracellular distribution is presently unclear. (Fig. 3a) . These results suggest that exogenous lyso-GEPC stimulated either the acetyltransferase to convert lyso-GEPC to AGEPC, or the acyltransferase to transform lyso-GEPC to alkylacyl-GPC. Also, it appears that the acetyltransferase may be more sensitive than the acyltransferase to the stimulatory action of this exogenous substrate. Finally, it has been reported that BSA has an influence on the recovery and the cellular uptake of [3H]AGEPC by various cell types [17, 25, 36] . Also, BSA has effects on PAF synthesis and PAF-induced platelet and neutrophil activation [38] . In agreement with these reports, it has been shown in the present study that BSA can improve the recovery of [3H]AGEPC from the plastic culture plates and can inhibit the cellular uptake of this compound by cultured rat Kupffer cells. Furthermore, BSA appeared to have a significant influence on the metabolism of [3H]AGEPC, mainly decreasing the formation of lyso-GEPC, which may be the result of the inhibition of the cellular uptake of [3H]AGEPC by BSA. This observation stands in contrast to a previous report in which BSA had no effect on the metabolism of [3H]AGEPC in MDCK cells [17] , but is in agreement with the report of Yamashita et al. [36] .
Even though certain phenomena cannot be explained definitively in this study, it is clear that Kupffer cells play an important role in the metabolism, including both catabolism and synthesis, of this potent phospholipid autacoid, and hence in the regulation of the PAF levels in certain pathophysiological situations to which the liver may be exposed.
